D-Hyoscyamine

CAS : 13269-35-7

Ref. 3D-NAA26935

Informations sur le produit

• Nom: D-Hyoscyamine
• Synonymes: (+)-Atropine, (+)-Hyoscyamine, (R)-Atropine, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2R)-3-hydroxy-2-phenylpropanoate, <span class="text-smallcaps">D</span>-Hyoscyamine, Benzeneacetic acid, α-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (αR)-, Benzeneacetic acid, α-(hydroxymethyl)-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, [3(R)-endo]-, d-Atropine, d-Hyoscyamine
• CAS: 13269-35-7

Description

D-Hyoscyamine is a potent anticancer agent that has been shown to induce apoptosis in cancer cells. It works by inhibiting kinases, which are enzymes that play a key role in the regulation of cell growth and division. D-Hyoscyamine has been tested on both human and Chinese hamster ovary cells, and has demonstrated significant anticancer activity. It is an analog of several kinase inhibitors, including cyclin-dependent kinase (CDK) inhibitors, which are commonly used in cancer therapy. In addition to its anticancer properties, D-Hyoscyamine has also been found to have potential therapeutic applications for other diseases such as Alzheimer's disease and Parkinson's disease. It is derived from urine and acts as a potent inhibitor of protein kinases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 289.4 g/mol
• Formule: C₁₇H₂₃NO₃
• Degré de pureté: Min. 95%